24th Jul 2006 07:30
Tepnel Life Sciences PLC24 July 2006 FOR IMMEDIATE RELEASE Tepnel Life Sciences plc ('Tepnel' or 'the Company') Tepnel signs Quality Agreement with Pfizer Ltd for CGMP Services Manchester, UK, 24th July, 2006 - Tepnel Life Sciences PLC (AIM: TED), the UK-based international Molecular Diagnostics and Research Products & Servicesgroup, is pleased to announce that it's Scottish pharmaceutical servicessubsidiary, Tepnel Scientific Services Ltd, has entered into a quality agreementwith Pfizer, one of the world's leading pharmaceutical companies. Under thescope of this agreement Tepnel has been selected as a supplier to Pfizer foranalytical chemistry and microbiological services. By continuing to provide ahigh quality service, Tepnel expects to have the opportunity to tender forfurther Pfizer business. Following Tepnel's recent placing which will, in part, fund the completion ofits 18,000 sq ft analytical testing facility in Scotland, Ben Matzilevich, CEO,commented: "We are delighted to announce this agreement with Pfizer which isproof of the high level of quality and regulatory compliance our systemsprovide. This agreement further strengthens Tepnel's position in the analyticaloutsourcing marketplace as a provider of regulatory compliant services to thepharmaceutical industry." About Tepnel Life Sciences plc Tepnel Life Sciences (AIM:TED) is a UK-based international life sciencesproducts and services group with two main divisions, Molecular Diagnostics andResearch Products & Services. The Company has laboratories, manufacturing andoperations in the USA, UK and France with 195 employees. TLS provides testkits, reagents and services to two highly synergistic markets, these beingMolecular Diagnostics and Biomedical Research. The company's strategy has beento identify high growth niche opportunities within these multi-billion poundmarkets. TLS focuses on these niche opportunities with internally developedproducts, patents, expertise and know-how as well as strategic acquisitions, todevelop a leadership position within these defined market segments. More information on Tepnel can be found at www.tepnel.com. Tepnel Life Sciences plcBen Matzilevich, CEO 0161 946 2200 De Facto Communications Richard Anderson 020 7861 3838 Notes to Editors About Tepnel Life Sciences plc Tepnel is a UK-based international life sciences company focused on moleculardiagnostics and research products and services including DNA purification kitsand reagents, scientific services for nucleic acid purification, drug analysis,genotyping and genetically modified foods. Tepnel was founded in 1992 to exploitDNA technology generated at UMIST (University of Manchester Institute of Scienceand Technology) and is quoted on the AIM segment of the London Stock Exchange(AIM: TED). More information on Tepnel can be found at www.tepnel.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TED.L